These findings showed that elevated expression of NXT1 correlates with more frequent TP53 mutations in HCC, implying a potential link between TP53 mutation and NXT1 levels in HCC progression, which warrants further investigation in future research. This evidence concerns the gene NXT1 and hepatocellular carcinoma.